Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jun 14, 2016 |
referred to ways and means delivered to assembly passed senate ordered to third reading cal.1683 committee discharged and committed to rules |
Jun 08, 2016 |
print number 5218a |
Jun 08, 2016 |
amend and recommit to finance |
Jun 02, 2016 |
reported and committed to finance |
Jan 06, 2016 |
referred to health |
May 07, 2015 |
referred to health |
Senate Bill S5218A
2015-2016 Legislative Session
Sponsored By
(D, IP) Senate District
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
(D) 15th Senate District
(D) Senate District
(R) Senate District
(R, C, IP) Senate District
2015-S5218 - Details
- See Assembly Version of this Bill:
- A2631
- Current Committee:
- Assembly Ways And Means
- Law Section:
- Public Health Law
- Laws Affected:
- Add Art 2 Title 4-A §§256 - 256-e, Pub Health L; add §95-i, St Fin L
- Versions Introduced in Other Legislative Sessions:
-
2009-2010:
S3663, A10139
2011-2012: S701, A458
2013-2014: S5186, A539, A8462
2017-2018: S4268, A2169
2019-2020: A6721
2021-2022: A3522
2023-2024: A469
2015-S5218 - Sponsor Memo
BILL NUMBER:S5218 TITLE OF BILL: An act to amend the public health law, in relation to creating the lupus research enhancement program; and to amend the state finance law, in relation to creating the lupus research enhancement fund PURPOSE: To promote basic and clinical research programs designed to reduce or prevent suffering from Lupus, by providing funding, if available, to state academic medical institutions within the state currently conducting or having an interest in conducting basic and clinical, social, translational, technological, epidemiological, and behavioral research on Lupus. SUMMARY OF SPECIFIC PROVISIONS: The Commissioner of Health shall establish within the department a Lupus research enhancement program through which the department shall make grants to state academic medical institutions within the state currently conducting or having an interest in conducting basic and clinical, social, translational, technological epidemiological and behavioral research on Lupus. The Commissioner shall establish a multidisciplinary Lupus research advisory council to monitor progress
2015-S5218 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5218 2015-2016 Regular Sessions I N S E N A T E May 7, 2015 ___________ Introduced by Sen. SAVINO -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to creating the lupus research enhancement program; and to amend the state finance law, in relation to creating the lupus research enhancement fund THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Article 2 of the public health law is amended by adding a new title 4-A to read as follows: TITLE IV-A LUPUS RESEARCH ENHANCEMENT ACT SECTION 256. SHORT TITLE. 256-A. LEGISLATIVE INTENT. 256-B. DEFINITION. 256-C. LUPUS RESEARCH ENHANCEMENT PROGRAM. 256-D. LUPUS RESEARCH ADVISORY COUNCIL. 256-E. LUPUS RESEARCH ENHANCEMENT FUND. S 256. SHORT TITLE. THIS TITLE SHALL BE KNOWN AND MAY BE CITED AS THE "LUPUS RESEARCH ENHANCEMENT ACT". S 256-A. LEGISLATIVE INTENT. 1. THE LEGISLATURE HEREBY FINDS THE FOLLOWING: (A) LUPUS IS A SERIOUS, COMPLEX, DEBILITATING AUTOIMMUNE DISEASE THAT CAN CAUSE INFLAMMATION AND TISSUE DAMAGE TO VIRTUALLY ANY ORGAN SYSTEM IN THE BODY, INCLUDING THE SKIN, JOINTS, OTHER CONNECTIVE TISSUE, BLOOD AND BLOOD VESSELS, HEART, LUNGS, KIDNEY, AND BRAIN. (B) THE LUPUS FOUNDATION OF AMERICA, INC. ESTIMATES THAT APPROXIMATELY 1.5 TO TWO MILLION AMERICANS LIVE WITH SOME FORM OF LUPUS; LUPUS AFFECTS WOMEN NINE TIMES MORE OFTEN THAN MEN AND EIGHTY PERCENT OF NEWLY DIAG- NOSED CASES OF LUPUS DEVELOP AMONG WOMEN OF CHILDBEARING AGE. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD01842-01-5
co-Sponsors
(D) 15th Senate District
(D) Senate District
(R) Senate District
(R, C, IP) Senate District
2015-S5218A (ACTIVE) - Details
- See Assembly Version of this Bill:
- A2631
- Current Committee:
- Assembly Ways And Means
- Law Section:
- Public Health Law
- Laws Affected:
- Add Art 2 Title 4-A §§256 - 256-e, Pub Health L; add §95-i, St Fin L
- Versions Introduced in Other Legislative Sessions:
-
2009-2010:
S3663, A10139
2011-2012: S701, A458
2013-2014: S5186, A539, A8462
2017-2018: S4268, A2169
2019-2020: A6721
2021-2022: A3522
2023-2024: A469
2015-S5218A (ACTIVE) - Sponsor Memo
BILL NUMBER: S5218A TITLE OF BILL : An act to amend the public health law, in relation to creating the lupus research enhancement program; and to amend the state finance law, in relation to creating the lupus research enhancement fund PURPOSE : To promote basic and clinical research programs designed to reduce or prevent suffering from Lupus, by providing funding, if available, to state academic medical institutions within the state currently conducting or having an interest in conducting basic and clinical, social, translational, technological, epidemiological, and behavioral research on Lupus. SUMMARY OF SPECIFIC PROVISIONS : The Commissioner of Health shall establish within the department a Lupus research enhancement program through which the department shall make grants to state academic medical institutions within the state currently conducting or having an interest in conducting basic and clinical, social, translational, technological epidemiological and behavioral research on Lupus. The Commissioner shall establish a multidisciplinary Lupus research advisory council to monitor progress
2015-S5218A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5218--A 2015-2016 Regular Sessions I N S E N A T E May 7, 2015 ___________ Introduced by Sens. SAVINO, ADDABBO, AVELLA, CROCI, GOLDEN, KENNEDY, LATIMER, PERALTA, PERKINS, STAVISKY, VENDITTO -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -- reported favorably from said committee and committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said commit- tee AN ACT to amend the public health law, in relation to creating the lupus research enhancement program; and to amend the state finance law, in relation to creating the lupus research enhancement fund THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Article 2 of the public health law is amended by adding a new title 4-A to read as follows: TITLE IV-A LUPUS RESEARCH ENHANCEMENT ACT SECTION 256. SHORT TITLE. 256-A. LEGISLATIVE INTENT. 256-B. DEFINITION. 256-C. LUPUS RESEARCH ENHANCEMENT PROGRAM. 256-D. LUPUS RESEARCH ADVISORY COUNCIL. 256-E. LUPUS RESEARCH ENHANCEMENT FUND. S 256. SHORT TITLE. THIS TITLE SHALL BE KNOWN AND MAY BE CITED AS THE "LUPUS RESEARCH ENHANCEMENT ACT". S 256-A. LEGISLATIVE INTENT. 1. THE LEGISLATURE HEREBY FINDS THE FOLLOWING: (A) LUPUS IS A SERIOUS, COMPLEX, DEBILITATING AUTOIMMUNE DISEASE THAT CAN CAUSE INFLAMMATION AND TISSUE DAMAGE TO VIRTUALLY ANY ORGAN SYSTEM EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD01842-02-6
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.